1. FDA approves first interchangeable biosimilar —AstraZeneca still eyes US vaccine filing despite another delay -- AstraZeneca and Amgen quietly admit tezepelumab defeat as the Dupixent challenger heads to FDA See more on our front page news
    Dismiss Notice
  2. Do you have general questions about dealing with sexual harassment or discrimination at work? Ask an attorney on this forum.
    Dismiss Notice

SIP Plan

Discussion in 'Genova Diagnostics' started by anonymous, Nov 21, 2018 at 3:17 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    True story and company as a whole is a complete shit show. So much chaos, you aren’t a salesperson, too many panels for that. Not for someone with a strong sales orientation. Decline and move on to greener pastures
     

  2. anonymous

    anonymous Guest

    How are they still around with fraudulent billing practices ? They don’t care for the reps nor the customers. Shit show it is ! Going down hill fast.